SMT201600084B - Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio - Google Patents

Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio

Info

Publication number
SMT201600084B
SMT201600084B SM201600084T SM201600084T SMT201600084B SM T201600084 B SMT201600084 B SM T201600084B SM 201600084 T SM201600084 T SM 201600084T SM 201600084 T SM201600084 T SM 201600084T SM T201600084 B SMT201600084 B SM T201600084B
Authority
SM
San Marino
Prior art keywords
trimethosphenyl
pyrimidindymmine
phosphonossi
ossazin
pyrid
Prior art date
Application number
SM201600084T
Other languages
English (en)
Italian (it)
Inventor
Karl-Heinz Giselbrecht
Michael Wolberg
Ulfried Felfer
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of SMT201600084B publication Critical patent/SMT201600084B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SM201600084T 2009-07-02 2016-03-24 Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio SMT201600084B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
SMT201600084B true SMT201600084B (it) 2016-04-29

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600084T SMT201600084B (it) 2009-07-02 2016-03-24 Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio

Country Status (21)

Country Link
US (3) US8299242B2 (enExample)
EP (1) EP2448950B1 (enExample)
JP (1) JP5739882B2 (enExample)
CN (1) CN102482305B (enExample)
AU (1) AU2010266213B2 (enExample)
BR (1) BRPI1011888A2 (enExample)
CA (1) CA2766801C (enExample)
CY (1) CY1117489T1 (enExample)
DK (1) DK2448950T3 (enExample)
EA (1) EA021657B1 (enExample)
ES (1) ES2565985T3 (enExample)
HR (1) HRP20160319T1 (enExample)
HU (1) HUE027212T2 (enExample)
ME (1) ME02388B (enExample)
PL (1) PL2448950T3 (enExample)
RS (1) RS54679B1 (enExample)
SG (1) SG176799A1 (enExample)
SI (1) SI2448950T1 (enExample)
SM (1) SMT201600084B (enExample)
UA (1) UA108077C2 (enExample)
WO (1) WO2011002999A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
US20110206661A1 (en) * 2010-02-24 2011-08-25 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
EP2736487B2 (en) * 2011-07-28 2024-08-28 Rigel Pharmaceuticals, Inc. New (trimethoxyphenylamino)pyrimidinyl formulations
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
MY170437A (en) 2012-06-19 2019-07-31 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
TW201410657A (zh) 2012-08-02 2014-03-16 Endo Pharmaceuticals Inc 經取代胺基-嘧啶衍生物
LT3083648T (lt) * 2013-12-20 2019-01-25 Rigel Pharmaceuticals, Inc. Farmacinis būdas ir tarpiniai junginiai
PL3419628T3 (pl) 2016-02-26 2021-05-31 Debiopharm International Sa Lek do leczenia zakażeń stopy cukrzycowej
EP3509578B1 (en) 2016-09-08 2022-12-21 Glykon Technologies Group, LLC Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same
JP2020536100A (ja) * 2017-10-04 2020-12-10 セルジーン コーポレイション シス−4−[2−{[(3s,4r)−3−フルオロキサン−4−イル]アミノ}−8−(2,4,6−トリクロロアニリノ)−9h−プリン−9−イル]−1−メチルシクロヘキサン−1−カルボキサミドの製造プロセス
HRP20230437T1 (hr) 2019-02-14 2023-07-07 Debiopharm International S.A. Formulacija afabicina, postupak izrade iste
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US303022A (en) 1884-08-05 Egg-beater
US324087A (en) 1885-08-11 Abel combs
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US20040024716A1 (en) 2002-04-12 2004-02-05 James Malatesta Mail sorting processes and systems
CN103169708B (zh) 2002-07-29 2018-02-02 里格尔药品股份有限公司 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
US7122542B2 (en) 2003-07-30 2006-10-17 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
US7449458B2 (en) * 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US20090114877A1 (en) * 2005-09-13 2009-05-07 Eisai R&D Management Co., Ltd. Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same
US8163902B2 (en) * 2006-11-21 2012-04-24 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
CN102482305B (zh) 2016-07-13
CA2766801C (en) 2018-03-13
US20110003986A1 (en) 2011-01-06
CN102482305A (zh) 2012-05-30
BRPI1011888A2 (pt) 2016-04-12
US20130274499A1 (en) 2013-10-17
HRP20160319T1 (hr) 2016-04-22
AU2010266213A1 (en) 2012-02-02
SI2448950T1 (sl) 2016-05-31
JP5739882B2 (ja) 2015-06-24
HUE027212T2 (en) 2016-10-28
RS54679B1 (sr) 2016-08-31
WO2011002999A1 (en) 2011-01-06
EP2448950A1 (en) 2012-05-09
AU2010266213B2 (en) 2015-06-18
CY1117489T1 (el) 2017-04-26
EP2448950B1 (en) 2016-01-13
DK2448950T3 (en) 2016-04-04
US8691798B2 (en) 2014-04-08
EA021657B1 (ru) 2015-08-31
US8481724B2 (en) 2013-07-09
CA2766801A1 (en) 2011-01-06
US8299242B2 (en) 2012-10-30
EA201270114A1 (ru) 2012-05-30
ME02388B (me) 2016-09-20
PL2448950T3 (pl) 2016-06-30
SG176799A1 (en) 2012-01-30
US20130018185A1 (en) 2013-01-17
UA108077C2 (xx) 2015-03-25
HK1169996A1 (zh) 2013-02-15
ES2565985T3 (es) 2016-04-08
JP2012532143A (ja) 2012-12-13

Similar Documents

Publication Publication Date Title
SMT201600084B (it) Sintesi del sale n4-(2,2-dimetil-4-[(diidrogeno fosfonossi)metil]-3-osso-5-pirido[1,4]ossazin-6-il)-5-fluoro-n2-(3,4,5-trimetossifenil)-2,4-pirimidindiammina disodio
FR17C1040I2 (fr) Derive antiviraux de 2,5-dibenzimidazol-5-yl-1-phenyl-pyrrolidine
HUE037412T2 (hu) Vetõmag-adagolóeszköz elrendezése mezõgazdasági gépen
EP2547271A4 (en) DYNAMIC BONE PLATE
EP2376098A4 (en) DIPEPTIDE-LINKED MEDICAL AGENTS
BRPI0922508A2 (pt) Análogos de nucleosídeo
ATE467426T1 (de) Dampfsterilisationssystem
HRP20150477T8 (hr) Postupci dobivanja derivata kinazolona
FI20085199L (fi) Esikammiojärjestely
EP2568880A4 (en) TRACKING WITH FIELD ALLOCATION
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
EP2258369A4 (en) PLASTER WITH MEDICAMENT PLASTER
EP2768531A4 (en) MEGLUMIN-STABILIZED ETANERCEPT FORMULATIONS
EP2265283A4 (en) Auristatin-DRUG-LINKER CONJUGATES
ES2590905T8 (es) Inhibidores de la tirosina quinasa de Bruton
LT3447061T (lt) Farmacinė vaisto forma, apimanti 5-fluor-2'-deoksiuridinofosforamidato darinį, skirtą naudoti vėžio gydymui
EP2451274A4 (en) Pharmaceutical compositions
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0918064A2 (pt) distribuidor de substância
EP2311518A4 (en) MEDICAL INSTRUMENT
EP2258421A4 (en) MEDICAL INSTRUMENT
BRPI0910853A2 (pt) cápsula com abertura de ar
BR112013015975A2 (pt) instrumento de cuidado oral.
BRPI1013616A2 (pt) medições diretas de desacoplamento de pressão arterial
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos